Cancer research is being held back by a shortage of high-quality, well-documented biological specimens. However, convincing hospitals to pool their specimens in a regional, national or international biobank is not always easy, adding to the logistical, technical, ethical, legal and IT obstacles of such a venture. Little by little, it seems, Europe is getting there.
